Trial intelligence / Profile preview

Washed Microbiota Transplantation for Chronic Kidney Disease

NCT05838118Unknown

Sponsor
The Second Affiliated Hospital of Nanjing Medical University
Start
Apr 2023
Primary completion
Dec 2024
Modality
Live Biotherapeutic Products
Countries
1
01

Overview

Randomised, open-label trial in chronic kidney disease (CKD) comparing Washed Microbiota Transplantation with Standard of Care (2 arms). Primary endpoints: Clinical Remission Efficacy Rate, Changes in Blood Creatinine at 12 week and 1 more. Status: unknown.

02

Drugs

washed microbiota transplantation
03

Conditions

chronic kidney disease (CKD)

Beyond the preview

Go deeper on NCT05838118.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05838118.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call